Advancing Small Molecule Formulation Development: Controlled Release CDMOs specialize in enhancing solubility, controlling release kinetics, and tailoring formulations to patient needs. With comprehensive support, they accelerate bringing safe, effective small molecule therapies to market. Learn more at renejix.com/formulation-development/.
